• Profile
Close

A longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adults

BMC Pulmonary Medicine Mar 02, 2019

Bramness JG, et al. – Researchers investigated whether cannabis use increases bronchial asthma risk via data analysis of 2,602 young adults followed for 13 years in a population-based longitudinal study—in addition to information obtained from the Norwegian national prescription database regarding asthma medication (β2-adrenergic receptor agonists and glucocorticoids for inhalation) prescribed. Researchers evaluated current cannabis use, sex, age, years of education, body mass index, and current smoking habits. The following factors were reported in association with the prescription of asthma medication: female sex, self-reported earlier asthma and allergies, daily tobacco smoking, and current cannabis use. According to the findings, cannabis conferred risk for bronchial asthma or use of asthma medication even when known risk factors were taken into account. Those at risk should avoid cannabis intake via smoking.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay